In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann Institute of Science started developing a DNA chip that could not only ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the ...
Synthetic biology is poised to tackle a range of challenges, from cleaning up pollutants with designer bacteria to the creation of bespoke gene therapies. But the transition from the laboratory to ...
In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann Institute of Science started developing a DNA chip that could not only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results